Results that show Amarin Corporation's (NASDAQ: AMRN) Vascepa brand of fish oil succeeded where similar attempts failed are terrific news for millions of patients at risk of heart attacks and strokes. It could also be great news for their insurers that don't want to cover pricey cholesterol drugs from Amgen, Inc. (NASDAQ: AMGN), Sanofi (NYSE: SNY), and Regeneron (NASDAQ: REGN).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,